Artivion (AORT) Revenue & Revenue Breakdown
Artivion Revenue Highlights
Latest Revenue (Y)
$354.00M
Latest Revenue (Q)
$98.02M
Main Segment (Y)
Products
Main Geography (Y)
UNITED STATES
Artivion Revenue by Period
Artivion Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $354.00M | 12.82% |
| 2022-12-31 | $313.79M | 5.00% |
| 2021-12-31 | $298.84M | 18.01% |
| 2020-12-31 | $253.23M | -8.32% |
| 2019-12-31 | $276.22M | 5.09% |
| 2018-12-31 | $262.84M | 38.55% |
| 2017-12-31 | $189.70M | 5.17% |
| 2016-12-31 | $180.38M | 23.63% |
| 2015-12-31 | $145.90M | 0.87% |
| 2014-12-31 | $144.64M | 2.75% |
| 2013-12-31 | $140.76M | 6.87% |
| 2012-12-31 | $131.72M | 10.11% |
| 2011-12-31 | $119.63M | 2.56% |
| 2010-12-31 | $116.64M | 4.44% |
| 2009-12-31 | $111.69M | 6.31% |
| 2008-12-31 | $105.06M | 10.87% |
| 2007-12-31 | $94.76M | 16.54% |
| 2006-12-31 | $81.31M | 17.36% |
| 2005-12-31 | $69.28M | 11.06% |
| 2004-12-31 | $62.38M | 4.79% |
| 2003-12-31 | $59.53M | -23.48% |
| 2002-12-31 | $77.80M | -11.26% |
| 2001-12-31 | $87.67M | 13.72% |
| 2000-12-31 | $77.10M | 15.55% |
| 1999-12-31 | $66.72M | 9.92% |
| 1998-12-31 | $60.70M | 19.25% |
| 1997-12-31 | $50.90M | 37.57% |
| 1996-12-31 | $37.00M | 27.59% |
| 1995-12-31 | $29.00M | 22.88% |
| 1994-12-31 | $23.60M | 11.32% |
| 1993-12-31 | $21.20M | - |
Artivion generated $354.00M in revenue during NA 2023, up 12.82% compared to the previous quarter, and up 134.68% compared to the same period a year ago.
Artivion Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-06-30 | $98.02M | 0.60% |
| 2024-03-31 | $97.43M | 4.02% |
| 2023-12-31 | $93.67M | 6.62% |
| 2023-09-30 | $87.85M | -1.57% |
| 2023-06-30 | $89.25M | 7.24% |
| 2023-03-31 | $83.23M | 4.83% |
| 2022-12-31 | $79.40M | 3.33% |
| 2022-09-30 | $76.84M | -4.36% |
| 2022-06-30 | $80.34M | 4.05% |
| 2022-03-31 | $77.21M | -2.75% |
| 2021-12-31 | $79.39M | 9.95% |
| 2021-09-30 | $72.21M | -5.18% |
| 2021-06-30 | $76.15M | 7.12% |
| 2021-03-31 | $71.09M | 4.70% |
| 2020-12-31 | $67.90M | 4.25% |
| 2020-09-30 | $65.13M | 21.13% |
| 2020-06-30 | $53.77M | -19.05% |
| 2020-03-31 | $66.43M | -4.69% |
| 2019-12-31 | $69.70M | 2.68% |
| 2019-09-30 | $67.88M | -4.58% |
| 2019-06-30 | $71.14M | 5.38% |
| 2019-03-31 | $67.50M | -0.43% |
| 2018-12-31 | $67.80M | 4.96% |
| 2018-09-30 | $64.60M | -5.69% |
| 2018-06-30 | $68.50M | 10.57% |
| 2018-03-31 | $61.95M | 17.27% |
| 2017-12-31 | $52.83M | 20.06% |
| 2017-09-30 | $44.00M | -7.99% |
| 2017-06-30 | $47.82M | 6.12% |
| 2017-03-31 | $45.06M | 0.07% |
| 2016-12-31 | $45.03M | -0.49% |
| 2016-09-30 | $45.25M | -3.89% |
| 2016-06-30 | $47.08M | 9.45% |
| 2016-03-31 | $43.02M | 7.98% |
| 2015-12-31 | $39.84M | 8.54% |
| 2015-09-30 | $36.70M | 3.31% |
| 2015-06-30 | $35.53M | 5.01% |
| 2015-03-31 | $33.83M | -8.94% |
| 2014-12-31 | $37.15M | 0.22% |
| 2014-09-30 | $37.07M | 6.86% |
| 2014-06-30 | $34.69M | -2.91% |
| 2014-03-31 | $35.73M | 0.77% |
| 2013-12-31 | $35.46M | -2.19% |
| 2013-09-30 | $36.25M | 8.14% |
| 2013-06-30 | $33.52M | -5.67% |
| 2013-03-31 | $35.54M | 8.34% |
| 2012-12-31 | $32.80M | -1.88% |
| 2012-09-30 | $33.43M | 0.73% |
| 2012-06-30 | $33.19M | 2.75% |
| 2012-03-31 | $32.30M | 6.26% |
| 2011-12-31 | $30.40M | 2.51% |
| 2011-09-30 | $29.65M | 0.94% |
| 2011-06-30 | $29.38M | -2.71% |
| 2011-03-31 | $30.20M | 3.33% |
| 2010-12-31 | $29.22M | 2.74% |
| 2010-09-30 | $28.44M | -2.80% |
| 2010-06-30 | $29.26M | -1.53% |
| 2010-03-31 | $29.72M | 3.85% |
| 2009-12-31 | $28.61M | 1.40% |
| 2009-09-30 | $28.22M | 0.20% |
| 2009-06-30 | $28.16M | 5.53% |
| 2009-03-31 | $26.69M | 4.53% |
| 2008-12-31 | $25.53M | -4.75% |
| 2008-09-30 | $26.80M | -1.29% |
| 2008-06-30 | $27.16M | 6.21% |
| 2008-03-31 | $25.57M | 1.99% |
| 2007-12-31 | $25.07M | - |
Artivion generated $98.02M in revenue during Q2 2024, up 0.60% compared to the previous quarter, and up 117.77% compared to the same period a year ago.
Artivion Revenue Breakdown
Artivion Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 |
|---|---|---|---|---|---|
| Other Products | $11.17M | $8.32M | $8.13M | - | - |
| Surgical Sealants | $68.02M | $65.38M | $70.71M | - | - |
| Aortic Stent Grafts | $107.47M | - | - | - | - |
| On X | $74.53M | $63.90M | $57.36M | $48.05M | $50.10M |
| Products | $261.19M | $230.35M | $221.60M | $179.30M | - |
| Aortic Stents And Stent Grafts | - | $92.75M | $85.39M | $61.66M | - |
| Preservation Services | - | $83.44M | $77.24M | $73.93M | $78.98M |
| Bioglue | - | - | - | $62.07M | $68.61M |
| Vascular Tissue | - | - | - | $35.85M | $38.10M |
| Photofix | - | - | - | $4.17M | $3.75M |
| Per Clot | - | - | - | $2.88M | $3.79M |
| Neopatch | - | - | - | $183.00K | - |
| Cardiogenesis Cardiac Laser Therapy | - | - | - | $464.00K | $6.02M |
| Cardiac Tissue | - | - | - | $37.89M | $40.88M |
| Jotec Ag | - | - | - | - | $64.97M |
Artivion's latest annual revenue breakdown by segment (product or service), as of Dec 23: Products (50.00%), Aortic Stent Grafts (20.57%), On X (14.27%), Surgical Sealants (13.02%), and Other Products (2.14%).
Quarterly Revenue by Product
| Product/Service | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aortic Stent Grafts | $32.10M | $27.44M | $25.52M | $28.36M | $26.15M | $19.67M | $23.83M | $25.51M | - | - | - | - | - | - | - | - | - | - | - | - |
| On X | $19.68M | $20.18M | $18.74M | $17.95M | $17.66M | $16.46M | $16.25M | $14.37M | $14.02M | $14.73M | $13.10M | $13.67M | $12.07M | $10.12M | $12.20M | $13.35M | $12.61M | $12.41M | $11.73M | - |
| Other Products | $2.35M | $3.01M | $3.25M | $3.13M | $1.78M | $1.74M | $2.88M | $1.98M | $1.65M | $2.42M | $2.22M | - | - | - | - | - | - | - | - | - |
| Products | $71.11M | $69.14M | $63.75M | $66.00M | $62.29M | $55.25M | $58.94M | $57.54M | $53.11M | $56.08M | $53.34M | $50.50M | - | - | - | - | - | - | - | - |
| Surgical Sealants | $16.98M | $18.51M | $16.23M | $16.57M | $16.70M | $17.37M | $15.97M | $15.68M | $16.54M | $17.86M | $17.83M | - | - | - | - | - | - | - | - | - |
| International Hospitals | - | - | - | - | - | $25.30M | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| International Distributor | - | - | - | - | - | $12.92M | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Domestic Hospitals | - | - | - | - | - | $40.79M | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Cardiogenesis | - | - | - | - | - | $389.00K | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Aortic Stents And Stent Grafts | - | - | - | - | - | - | - | - | - | $20.90M | $21.06M | $20.20M | - | - | - | - | - | - | - | - |
| Photofix | - | - | - | - | - | - | - | - | - | - | - | - | $1.11M | $1.13M | $880.00K | $1.04M | $1.00M | $1.09M | $935.00K | $730.00K |
| Bioglue | - | - | - | - | - | - | - | - | - | - | - | - | $17.08M | $15.81M | $12.44M | $16.74M | - | - | - | - |
| Cardiac Tissue | - | - | - | - | - | - | - | - | - | - | - | - | $9.13M | $10.68M | $8.06M | $10.03M | $10.14M | $11.30M | $10.50M | $8.93M |
| Cardiogenesis Cardiac Laser Therapy | - | - | - | - | - | - | - | - | - | - | - | - | $106.00K | $83.00K | $164.00K | $111.00K | $1.05M | $1.35M | $1.90M | $1.71M |
| Neopatch | - | - | - | - | - | - | - | - | - | - | - | - | $64.00K | $58.00K | - | - | - | - | - | - |
| Per Clot | - | - | - | - | - | - | - | - | - | - | - | - | $801.00K | $724.00K | $497.00K | $860.00K | $981.00K | $980.00K | $784.00K | $1.05M |
| Preservation Services | - | - | - | - | - | - | - | - | - | - | - | - | $17.39M | - | - | - | - | - | - | - |
| Vascular Tissue | - | - | - | - | - | - | - | - | - | - | - | - | $8.20M | $9.29M | $9.98M | $9.36M | $9.09M | $9.47M | $10.17M | - |
| Jotec Ag | - | - | - | - | - | - | - | - | - | - | - | - | - | $15.29M | $13.17M | $15.27M | $16.04M | $15.77M | $17.21M | $15.95M |
| Nexus | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $200.00K | - | - | - | - |
| Bio Glue And Bio Foam | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $15.68M | $17.93M | $17.22M |
Artivion's latest quarterly revenue breakdown by segment (product or service), as of Mar 24: Products (50.00%), Aortic Stent Grafts (22.57%), On X (13.84%), Surgical Sealants (11.94%), and Other Products (1.65%).
Artivion Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 |
|---|---|---|---|---|---|
| Non-US | $174.52M | $152.68M | - | - | - |
| UNITED STATES | $179.49M | $161.11M | - | - | - |
| U | - | - | $151.15M | $138.27M | $150.55M |
| Non Us | - | - | $147.69M | $114.95M | $125.67M |
Artivion's latest annual revenue breakdown by geography, as of Dec 23: UNITED STATES (50.70%), and Non-US (49.30%).
Quarterly Revenue by Country
| Country | Mar 24 |
|---|---|
| Asia Pacific Segment | $7.61M |
| Europe, the Middle East, and Africa Segments | $33.59M |
| Latin America Segment | $5.31M |
| North America Segment | $50.93M |
Artivion's latest quarterly revenue breakdown by geography, as of Mar 24: North America Segment (52.27%), Europe, the Middle East, and Africa Segments (34.47%), Asia Pacific Segment (7.81%), and Latin America Segment (5.45%).
Artivion Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| ITGR | Integer | $1.60B | $753.01M |
| CNMD | CONMED | $1.24B | $332.10M |
| AVNS | Avanos Medical | $673.30M | $171.70M |
| AORT | Artivion | $354.00M | $98.02M |
| ANIK | Anika Therapeutics | $166.66M | $41.92M |
| ESTA | Establishment Labs | $165.15M | $44.12M |
| AXGN | AxoGen | $159.01M | $47.91M |
| KIDS | OrthoPediatrics | $148.73M | $52.80M |
| SIBN | SI-BONE | $138.89M | $39.97M |
| SRDX | Surmodics | $132.58M | $30.34M |
| SGHT | Sight Sciences | $81.06M | $21.37M |
| LUNG | Pulmonx | $68.67M | $20.78M |
| NPCE | NeuroPace | $65.42M | $18.12M |
| CVRX | CVRx | $39.30M | $11.81M |
| OFIX | Orthofix Medical | $100.00K | $198.62M |
AORT Revenue FAQ
What is Artivion’s yearly revenue?
Artivion's yearly revenue for 2023 was $354M, representing an increase of 12.82% compared to 2022. The company's yearly revenue for 2022 was $313.79M, representing an increase of 5.00% compared to 2021. AORT's yearly revenue for 2021 was $298.84M, representing an increase of 18.01% compared to 2020.
What is Artivion’s quarterly revenue?
Artivion's quarterly revenue for Q2 2024 was $98.02M, a 0.60% increase from the previous quarter (Q1 2024), and a 9.82% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $97.43M, a 4.02% increase from the previous quarter (Q4 2023), and a 17.06% increase year-over-year (Q1 2023). AORT's quarterly revenue for Q4 2023 was $93.67M, a 6.62% increase from the previous quarter (Q3 2023), and a 17.98% increase year-over-year (Q4 2022).
What is Artivion’s revenue growth rate?
Artivion's revenue growth rate for the last 3 years (2021-2023) was 18.46%, and for the last 5 years (2019-2023) was 28.16%.
What are Artivion’s revenue streams?
Artivion's revenue streams in c 23 are Other Products, Surgical Sealants, Aortic Stent Grafts, On X, and Products. Other Products generated $11.17M in revenue, accounting 2.14% of the company's total revenue, up 34.31% year-over-year. Surgical Sealants generated $68.02M in revenue, accounting 13.02% of the company's total revenue, up 4.03% year-over-year. Aortic Stent Grafts generated $107.47M in revenue, accounting 20.57% of the company's total revenue On X generated $74.53M in revenue, accounting 14.27% of the company's total revenue, up 16.62% year-over-year. Products generated $261.18M in revenue, accounting 50.00% of the company's total revenue, up 13.38% year-over-year.
What is Artivion’s main source of revenue?
For the fiscal year ending Dec 23, the largest source of revenue of Artivion was Products. This segment made a revenue of $261.18M, representing 50.00% of the company's total revenue.